House
GuidelinesCalculatorsPricingBlog
Ask House ↗
Guidelines↗Calculators↗Pricing↗Blog↗
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
Back to guidelines
Cardiology

Perioperative cardiovascular management for non-cardiac surgery

AHA / ACC · 2024 edition / updateSource checked 29 October 2026
Read the source publication
House clinical summary

Scope

These AHA highlights summarise selected recommendations from the guideline on cardiovascular management around noncardiac surgery. They emphasise a stepwise assessment, cardiovascular testing and treatment for appropriate indications, coordinated care for complex disease, and attention to perioperative medication and follow-up decisions. The source provides useful principles but does not reproduce the complete assessment algorithm, anticoagulant interruption schedules or postoperative treatment regimens.

Written by House with AI assistance · AI-assisted source check 29 October 2026.

This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.

Assessment and testing

  • Use a stepwise perioperative cardiac assessment to decide whether surgery can proceed or whether further evaluation is warranted first. [1]
  • Screen and treat cardiovascular disease using the same indications that would apply outside the surgical setting. Time decisions carefully to limit unnecessary surgical delay and avoid low-benefit over-screening or over-treatment. [1]
  • For low-risk patients having low-risk surgery, minimise stress testing. It is appropriate only when there would also be an indication outside the perioperative setting. [1]
  • Plan care through a team when the patient has complex cardiovascular anatomy or unstable cardiovascular disease. [1]

Medication decisions

  • Discontinue SGLT2 inhibitors 3-4 days before surgery to reduce the risk of associated perioperative ketoacidosis. [1]
  • Individualise perioperative decisions for warfarin and novel oral anticoagulants, including interruption, bridging and postoperative restart, according to their indications. [1]

Postoperative assessment and follow-up

  • Do not disregard myocardial injury after noncardiac surgery. The highlights note its consequences and that trials of treatment and risk mitigation are ongoing. [1]
  • When atrial fibrillation is identified during or after noncardiac surgery, arrange postoperative and post-discharge follow-up to address reversible causes and consider rhythm control and long-term anticoagulation in view of increased stroke risk. [1]

Limitations and use

  • This is a focused summary of the AHA Top Things to Know page, not the full guideline or its evidence tables.
  • The source does not give risk-score thresholds, the complete testing algorithm, anticoagulant interruption or restart schedules, or a treatment regimen for myocardial injury after surgery.
  • The numbered highlights and formal citation identify the 2024 guideline. A later webpage update date is not treated as a new guideline edition.
  • This House summary is based on the linked focused or condensed recommendation sources; it does not represent the complete original publication.

This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.

Summary sources

  1. 1
    Perioperative cardiovascular management for non-cardiac surgery — focused recommendation source

    Selected recommendation material consulted

Clinical guideline

Publication details

Issuing organisation
AHA / ACC
Resource type
Clinical guideline · House clinical summary

Earlier House summaries: preoperative cardiac evaluation for non cardiac surgery aha

The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.

On this page

  • Scope
  • Assessment and testing
  • Medication decisions
  • Postoperative assessment and follow-up
  • Limitations and use
  • Summary sources
  • Publication details
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House